E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Critical evaluation of promotional drug literature based on the WHO criteria

Sameer Pandit, Rhythm.

Abstract
Background: Pharmaceutical companies use drug promotional literature (DPL) as an important mode to promote their products and it also influences the prescribing behavior of prescribers. However, information provided in promotional literature may be inadequate or misleading which may lead to irrational prescribing. The WHO has provided ethical criteria for medicinal drug promotion.

Aims and Objectives: This study was undertaken with the aim to analyze the promotional drug literature for their compliance to the WHO ethical criteria for medicinal drug promotion, 1988.

Materials and Methods: A cross-sectional and observational study was carried out to evaluate the extent to which promotional literature collected from private physicians meet the WHO ethical criteria for medicinal drug promotion. A total of 100 promotional literature were evaluated for their fulfillment of the WHO criteria.

Results: Information regarding brand name, generic name of drugs, dosage form, therapeutic uses, and active ingredient per dosage form was present in most of the promotional drug literature in the present study. However, the information such as safety profile of drugs, precautions, warnings, and drug interactions was not mentioned in most of the DPLs.

Conclusion: The majority of DPLs evaluated in this study did not comply with the WHO guidelines for medical drug promotion. As prescribing behavior of physicians is influenced by promotional literatures, regular training of health professionals and medical students regarding critical analysis of DPLs can help in ethical and rational prescribing.

Key words: Drug Promotional Literature; Pharmaceutical Companies; WHO


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Sameer Pandit
Articles by Rhythm
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Pandit S, Rhythm . Critical evaluation of promotional drug literature based on the WHO criteria. Natl J Physiol Pharm Pharmacol. 2022; 12(12): 2033-2036. doi:10.5455/njppp.2022.12.04171202211042022


Web Style

Pandit S, Rhythm . Critical evaluation of promotional drug literature based on the WHO criteria. https://www.njppp.com/?mno=1161 [Access: February 04, 2023]. doi:10.5455/njppp.2022.12.04171202211042022


AMA (American Medical Association) Style

Pandit S, Rhythm . Critical evaluation of promotional drug literature based on the WHO criteria. Natl J Physiol Pharm Pharmacol. 2022; 12(12): 2033-2036. doi:10.5455/njppp.2022.12.04171202211042022



Vancouver/ICMJE Style

Pandit S, Rhythm . Critical evaluation of promotional drug literature based on the WHO criteria. Natl J Physiol Pharm Pharmacol. (2022), [cited February 04, 2023]; 12(12): 2033-2036. doi:10.5455/njppp.2022.12.04171202211042022



Harvard Style

Pandit, S. & Rhythm, . (2022) Critical evaluation of promotional drug literature based on the WHO criteria. Natl J Physiol Pharm Pharmacol, 12 (12), 2033-2036. doi:10.5455/njppp.2022.12.04171202211042022



Turabian Style

Pandit, Sameer, and Rhythm. 2022. Critical evaluation of promotional drug literature based on the WHO criteria. National Journal of Physiology, Pharmacy and Pharmacology, 12 (12), 2033-2036. doi:10.5455/njppp.2022.12.04171202211042022



Chicago Style

Pandit, Sameer, and Rhythm. "Critical evaluation of promotional drug literature based on the WHO criteria." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 2033-2036. doi:10.5455/njppp.2022.12.04171202211042022



MLA (The Modern Language Association) Style

Pandit, Sameer, and Rhythm. "Critical evaluation of promotional drug literature based on the WHO criteria." National Journal of Physiology, Pharmacy and Pharmacology 12.12 (2022), 2033-2036. Print. doi:10.5455/njppp.2022.12.04171202211042022



APA (American Psychological Association) Style

Pandit, S. & Rhythm, . (2022) Critical evaluation of promotional drug literature based on the WHO criteria. National Journal of Physiology, Pharmacy and Pharmacology, 12 (12), 2033-2036. doi:10.5455/njppp.2022.12.04171202211042022